Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Mozaffari S, Nikfar S, Abdollahi M. Expert Opin Drug Metab Toxicol 2024 Apr 26. doi: 10.1080/17425255.2024.2348488.

Read + Share

Amedeo Smart

Independent Medical Education

Mozaffari S, Nikfar S, Abdollahi M. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert Opin Drug Metab Toxicol 2024 Apr 26. doi: 10.1080/17425255.2024.2348488.
PMID: 38668452